Literature DB >> 16969621

Preoperative assessment of the circumferential margin in rectal cancer is more informative in treatment planning than the T stage.

S V R C Wolberink1, R G H Beets-Tan, I D Nagtegaal, T Wiggers.   

Abstract

Preventing local recurrence in rectal cancer means achieving a free circumferential resection margin (CRM) through an optimal combination of surgery, radiotherapy and chemotherapy. This requires a differentiation between primary resectable and locally advanced cancers. The T staging used, while being a powerful marker of prognosis, has two major downsides. First, accuracy of preoperative predictions of the T stage is unacceptably low. Second, a T3 tumor can be either primary resectable or locally advanced. A review of the literature was performed to establish the value of the CRM as the preferred preoperative staging classification, and to establish the feasibility of predicting the CRM using modern day, high-resolution imaging techniques. We advocate using the CRM as preoperative staging classification. Magnetic resonance imaging and multislice computed tomography offer an accurate pre-operative prediction of the CRM, and staging by means of predicted CRM offers the ideal combination of accuracy and clinical relevance.

Entities:  

Mesh:

Year:  2006        PMID: 16969621     DOI: 10.1007/s10151-006-0275-0

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  6 in total

1.  Modified neoadjuvant short-course radiation therapy in uT3 rectal carcinoma: low local recurrence rate with unchanged overall survival and frequent morbidity.

Authors:  Rainer Kube; Henry Ptok; David Jacob; Jörg Fahlke; Pawel Mroczkowski; Hans Lippert; Gunther Ziegenhardt; Uwe Schmidt; Ingo Gastinger
Journal:  Int J Colorectal Dis       Date:  2009-10-31       Impact factor: 2.571

Review 2.  Multidisciplinary treatment of rectal cancer in 2014: where are we going?

Authors:  Andrea Vignali; Paola De Nardi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

3.  Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status.

Authors:  Joachim Strassburg; Theo Junginger; Trong Trinh; Olaf Püttcher; Katja Oberholzer; Richard J Heald; Paul Hermanek
Journal:  Int J Colorectal Dis       Date:  2008-07-17       Impact factor: 2.571

4.  Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review.

Authors:  Michael R Torkzad; Lars Påhlman; Bengt Glimelius
Journal:  Insights Imaging       Date:  2010-08-15

5.  The accuracy of multi-detector row computerized tomography in staging rectal cancer compared to endoscopic ultrasound.

Authors:  Abdulrahman M Aljebreen; Nahla A Azzam; Ahmad M Alzubaidi; Mohamed S Alsharqawi; Thamer A Altraiki; Othman R Alharbi; Majid A Almadi
Journal:  Saudi J Gastroenterol       Date:  2013 May-Jun       Impact factor: 2.485

Review 6.  The modern anatomical surgical approach to localised rectal cancer.

Authors:  R G Orsini; T Wiggers; M C DeRuiter; P Quirke; R G Beets-Tan; C J van de Velde; H J T Rutten
Journal:  EJC Suppl       Date:  2013-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.